Replies to post #574441 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Lykiri. thank you for that additional context. Those DCVax-L + poly-ICLC results are very impressive.

I believe that why Doc Logic was suggesting that those interim results give NWBio the upper hand in negotiating future combo partnership agreements with the likes of Merck, Bristol Myers Squibb, and other large BPs who have a PD-1 or PDL-1 inhibitors.

The overall survival results with just DCVax-L and poly-ICLC together, without any checkpoint inhibitor, are already phenomenal.